Table 1.
Baseline characteristics
| Characteristic | Study participants (n = 14) |
|---|---|
| Age (years) | 63.9 (7.9) |
| Male sex, n (%) | 9 (64.3) |
| Race, n (%) | |
| White | 13 (92.9) |
| Asian | 1 (7.1) |
| Diabetes duration (years) | 10.2 (5.2) |
| Body weight (kg) | 98.7 (15.9) |
| BMI (kg/m2) | 31.9 (4.2) |
| Fasting plasma glucose (mmol/L) | 8.1 (1.4) |
| HbA1c (%) | 7.2 (0.6) |
| HbA1c (mmol/mol) | 55 (6.6) |
| SBP (mmHg) | 128.6 (13.6) |
| DBP (mmHg) | 74.7 (7.5) |
| eGFR (CKD-EPI) (mL/min/1.73 m2) | 94.3 (10.9) |
| UACR (mg/mmol), median (25th–75th percentile) | 0.8 (0.5–2.8) |
| Hemoglobin (g/L) | 137.9 (13.0) |
| Hematocrit (L/L) | 0.4 (0.0) |
| Metformin, n (%) | 14 (100) |
| SU derivative, n (%) | 5 (35.7) |
Data are mean (SD) unless otherwise indicated. Blood pressure recorded in supine position. CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; eGFR, estimated glomerular filtration rate; UACR, urinary albumin-to-creatinine ratio.